Myeloma Research News

July 15, 2019July 15, 2019

Specific DNA Rearrangement Predicts Treatment Resistance, Poor Outcomes in Multiple Myeloma, Study Suggests

This post was originally published on this siteThis post was originally published on this site A genomic rearrangement involving the immunoglobulin lambda (IgL) ... Read more

July 12, 2019July 12, 2019

FDA Will Review Isatuximab as Potential Therapy for Hard-to-treat Multiple Myeloma

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Admnistration (FDA) has agreed ... Read more

July 10, 2019July 10, 2019

FDA Lifts Hold on Phase 3 Trial Testing Venclexta in Myeloma Patients with Common Genetic Abnormality

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

July 8, 2019July 8, 2019

FDA Approves Xpovio Combo for Heavily Treated RRMM Patients

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

July 3, 2019July 3, 2019

Scientists Find ‘On/off Switch’ of Malignant MM Cancer Cells, May Lead to New Therapies, Study Says

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site Scientists discovered a set of genes that work ... Read more

July 1, 2019July 1, 2019

FDA Approves Darzalex-Revlimid-dexamethasone Combo to Treat Newly Diagnosed Multiple Myeloma

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site The U.S. Food and Drug Administration (FDA) has ... Read more

June 28, 2019June 28, 2019

Empliciti Combo Prolongs Survival in Difficult-to-Treat Multiple Myeloma, New Phase 2 Trial Data Show

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site Adding Empliciti (elotuzumab) to a regimen including Pomalyst (pomalidomide) ... Read more

June 26, 2019June 26, 2019

Selinexor Combo Yields Strong Responses in Difficult-to-treat Multiple Myeloma

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site Selinexor in combination with dexamethasone and Pomalyst (pomalidomide) leads ... Read more

June 24, 2019June 24, 2019

MMRF Launches CureCloud Data Hub to Identify Treatment Targets

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site Addressing the need for shared, comprehensive data to ... Read more

June 21, 2019June 21, 2019

Darzalex Combo Extends Survival in Newly Diagnosed Myeloma Patients, Phase 3 Trial Shows

Myeloma Research News

This post was originally published on this siteThis post was originally published on this site Adding Darzalex (daratumumab) to the standard first-line treatment of Revlimid ... Read more